Table 3.

Mab Sensitivity MVA for 60-day mortality (N = 64). (a) Mab Sensitivity Reduced MVA for 60-day Mortality (b) Mab Sensitivity Reduced MVA for Hospitalization.

(a)
	Odds Ratio	95% Confidence Interval	p
Vaccinated	0.59	0.09–4.04	0.590
Age	1.23	1.09–1.38	0.001
Female Gender	0.12	0.02–0.67	0.017
Kidney Transplant *	50.57	3.92–651.83	0.003
(b)
Vaccinated	0.83	0.22–3.12	0.784
Age	1.06	1.00–1.13	0.048
Female Gender	0.60	0.17–2.13	0.423
Kidney Transplant *	5.4	0.79–37.17	0.085

MVA: Multi-variable analysis, Mab: Monoclonal antibody. * As compared to Liver Transplants